Terms: = Kidney tumors AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
80 results:
1. Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with alk fusion: a case report and review of the literature.
Zhang P; Xu J; Wu Q; Qian J; Wang S
Diagn Pathol; 2024 Apr; 19(1):58. PubMed ID: 38616252
[TBL] [Abstract] [Full Text] [Related]
2. [A case of crizotinib-associated renal cysts].
Quan LL; Huang P; Liang YC; Chen FW; Liu SB; Xin WW
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):356-359. PubMed ID: 38599812
[TBL] [Abstract] [Full Text] [Related]
3. Unlocking Prognostic Genes and Multi-Targeted Therapeutic Bioactives from Herbal Medicines to Combat Cancer-Associated Cachexia: A Transcriptomics and Network Pharmacology Approach.
Muthamil S; Muthuramalingam P; Kim HY; Jang HJ; Lyu JH; Shin UC; Go Y; Park SH; Lee HG; Shin H; Park JH
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203330
[TBL] [Abstract] [Full Text] [Related]
4. alk-rearranged renal cell carcinoma (alk-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
Doğan K; Onder E
Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
[TBL] [Abstract] [Full Text] [Related]
5. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of prognosis and related factors in oldest-old patients with left-side or right-side colon cancer after hemicolectomy].
An Q; Shi JX; Cui J; Li ZJ; Ma FH; Xiao G; Jia WW; Tang DN; Zhao G; Wu GJ
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1666-1672. PubMed ID: 37302856
[No Abstract] [Full Text] [Related]
7. Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant.
Simonet M; Dominguez Gutierrez A; Territo A; Prudhomme T; Campi R; Andras I; Baboudjian M; Hevia V; Boissier R;
World J Urol; 2022 Dec; 40(12):2901-2910. PubMed ID: 36367586
[TBL] [Abstract] [Full Text] [Related]
8. Diterpene promptly executes a non-canonical autophagic cell death in doxorubicin-resistant lung cancer.
Chiu WJ; Lin CS; Lin SR; Chen TH; Wu CJ; Busa P; Long H; Chen CC; Tseng FJ; Fu YS; Weng CF
Biomed Pharmacother; 2022 Sep; 153():113443. PubMed ID: 36076558
[TBL] [Abstract] [Full Text] [Related]
9. Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non-small cell lung cancer patients with impaired renal function: RESTART trial.
Shiraishi Y; Kishimoto J; Shimose T; Toi Y; Sugawara S; Okamoto I
BMC Cancer; 2022 Sep; 22(1):964. PubMed ID: 36076179
[TBL] [Abstract] [Full Text] [Related]
10. alk rearrangement-associated renal cell carcinoma morphologically mimicking mucinous tubular and spindle cell carcinoma: a case report.
Kai K; Tobu S; Kido S; Mikami S; Takeuchi K; Dobashi A; Togashi Y; Noguchi M; Aishima S
Diagn Pathol; 2022 Jun; 17(1):52. PubMed ID: 35718773
[TBL] [Abstract] [Full Text] [Related]
11. alk Translocation in alk-Positive Mesenchymal tumors: Diagnostic and Therapeutic Insights.
Jung M; Moon KC; Bae J; Kim TM; Kim M; Jeon YK; Lee C
Arch Pathol Lab Med; 2022 Dec; 146(12):1460-1470. PubMed ID: 35438749
[TBL] [Abstract] [Full Text] [Related]
12. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the treatment of Cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
13. Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma.
Chan VW; Osman FH; Cartledge J; Gregory W; Kimuli M; Vasudev NS; Ralph C; Jagdev S; Bhattarai S; Smith J; Lenton J; Wah TM
Eur Radiol; 2022 Sep; 32(9):5811-5820. PubMed ID: 35384457
[TBL] [Abstract] [Full Text] [Related]
14. Impacts of Neighborhood Characteristics and Surgical treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients.
Cruz A; Dickerson F; Pulling KR; Garcia K; Gachupin FC; Hsu CH; Chipollini J; Lee BR; Batai K
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206240
[TBL] [Abstract] [Full Text] [Related]
15. Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy.
Mizuno R; Takamatsu K; Yasumizu Y; Tanaka N; Takeda T; Morita S; Matsumoto K; Kosaka T; Asanuma H; Mikami S; Oya M
Urol Int; 2022; 106(11):1145-1149. PubMed ID: 35139522
[TBL] [Abstract] [Full Text] [Related]
16. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
[TBL] [Abstract] [Full Text] [Related]
17. Drug interaction profile of TKI alectinib allows effective and safe treatment of alk+ lung cancer in the kidney transplant recipient.
Bilek O; Holanek M; Jurica J; Stepankova S; Vasina J; Selingerova I; Poprach A; Borilova S; Kazda T; Kiss I; Zdrazilova-Dubska L
Int Immunopharmacol; 2021 Oct; 99():108012. PubMed ID: 34339964
[TBL] [Abstract] [Full Text] [Related]
18. The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study.
Guven DC; Acar R; Yekeduz E; Bilgetekin I; Baytemur NK; Erol C; Ceylan F; Sendur MA; Demirci U; Urun Y; Karadurmus N; Erman M; Kilickap S
Curr Probl Cancer; 2021 Dec; 45(6):100760. PubMed ID: 34130864
[TBL] [Abstract] [Full Text] [Related]
19. Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data.
Barthélémy P; Rioux-Leclercq N; Thibault C; Saldana C; Borchiellini D; Chevreau C; Desmoulins I; Gobert A; Hilgers W; Khalil A; Lemoine N; Schlürmann-Constans F; Négrier S
Cancer Treat Rev; 2021 Jun; 97():102191. PubMed ID: 34015728
[TBL] [Abstract] [Full Text] [Related]
20. Complex renal cysts combined with hemorrhage during crizotinib treatment for alk-rearranged lung adenocarcinoma.
Yang L; Gu J; Niu X
Cancer Treat Res Commun; 2021; 27():100373. PubMed ID: 33865115
[TBL] [Abstract] [Full Text] [Related]
[Next]
